Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710489 · ClinicalTrials.gov registry record
Potential Research Study Participant Registry
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 265
- Enrollment target
NCT00710489: Completed study, sponsored by University of California, Davis.
NCT00710489 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 265 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00710489 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 265 participants
- Enrollment target
Study Summary
The purpose of the potential research study participant registry is to keep potential research subjects informed about any future research studies in which they may meet the criteria for enrollment. The purpose of this study is also to assist current and future clinical trials with recruitment of subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2008-05 |
| Est. Completion | 2018-09-05 |
What the finished NCT00710489 record still lists
NCT00710489 is an observational study that tracks outcomes without assigning an intervention. The registered 265 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00710489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00710489 about?
NCT00710489 is a clinical study titled "Potential Research Study Participant Registry". The purpose of the potential research study participant registry is to keep potential research subjects informed about any future research studies in which they may meet the criteria for enrollment. The purpose of this study is also to assist current and future clinical trials with recruitment of su...
What is the current status of trial NCT00710489?
This trial is currently completed. The enrollment target is 265 participants. The study started on 2008-05. Estimated completion is 2018-09-05.
Who is sponsoring clinical trial NCT00710489?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443126 · 265 participants · Phase 1
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
- NCT05470491 · 265 participants · Phase 1
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- NCT07301905 · 265 participants · NA
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
- NCT07470853 · 265 participants · Phase 1
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia